Cizzle Biotechnology Holdings PLC (GB:CIZ) has released an update.
Cizzle Biotechnology Holdings PLC, a UK-based developer of diagnostic technologies, has successfully passed all resolutions during its recent Annual General Meeting, including the re-appointment of key directors and the re-appointment of PKF Littlejohn LLP as the company’s auditor. Shareholders showed strong support with high percentages of votes cast in favor of the proposed resolutions. The company, which emerged from the University of York, is focused on innovating early detection of lung cancer through a blood test that identifies the CIZ1B biomarker.
For further insights into GB:CIZ stock, check out TipRanks’ Stock Analysis page.
